|
US20100111856A1
(en)
*
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
USRE47223E1
(en)
*
|
2005-06-20 |
2019-02-05 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
CL2008001334A1
(es)
|
2007-05-08 |
2008-09-22 |
Genentech Inc |
Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
|
|
EP2185188B1
(en)
|
2007-08-22 |
2014-08-06 |
Medarex, L.L.C. |
Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
|
|
MY188455A
(en)
|
2007-10-19 |
2021-12-09 |
Genentech Inc |
Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates
|
|
MX2011000509A
(es)
|
2008-07-15 |
2011-04-05 |
Genentech Inc |
Conjugados derivados de antraciclina, proceso para su preparacion y su uso como compuestos antitumorales.
|
|
AU2008364786B2
(en)
|
2008-12-05 |
2014-04-03 |
The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services |
Blocking mesothelin peptide fragments
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
EP2400992B1
(en)
|
2009-02-27 |
2015-07-22 |
Genentech, Inc. |
Methods and compositions for protein labelling
|
|
CA2768204A1
(en)
|
2009-07-15 |
2011-01-20 |
Aimm Therapeutics B.V. |
Gram-positive bacteria specific binding compounds
|
|
ES2621874T3
(es)
|
2010-03-26 |
2017-07-05 |
Memorial Sloan-Kettering Cancer Center |
Anticuerpos para MUC16 y métodos de uso de los mismos
|
|
JP5767207B2
(ja)
|
2010-03-26 |
2015-08-19 |
協和発酵キリン株式会社 |
新規修飾部位導入抗体および抗体フラグメント
|
|
US20110256157A1
(en)
|
2010-04-15 |
2011-10-20 |
Spirogen Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP2013534520A
(ja)
|
2010-06-08 |
2013-09-05 |
ジェネンテック， インコーポレイテッド |
システイン操作抗体及びコンジュゲート
|
|
ES2544608T3
(es)
|
2010-11-17 |
2015-09-02 |
Genentech, Inc. |
Conjugados de anticuerpo y de alaninil-maitansinol
|
|
UA115641C2
(uk)
*
|
2010-12-20 |
2017-11-27 |
Дженентек, Інк. |
Виділене антитіло, яке зв'язує мезотелін, та імунокон'югат, що його містить
|
|
US9540438B2
(en)
|
2011-01-14 |
2017-01-10 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof
|
|
IL279304B
(en)
|
2011-02-15 |
2022-07-01 |
Immunogen Inc |
Method for producing an indolinobenzodiazepine
|
|
CA2830349C
(en)
|
2011-03-17 |
2019-07-16 |
The University Of Birmingham |
Re-directed immunotherapy
|
|
UY34317A
(es)
|
2011-09-12 |
2013-02-28 |
Genzyme Corp |
Anticuerpo antireceptor de célula T (alfa)/ß
|
|
HRP20151374T1
(hr)
|
2011-10-14 |
2016-01-15 |
Medimmune Limited |
Pirolobenzodiazepini i njihovi konjugati
|
|
SG11201401422VA
(en)
*
|
2011-10-27 |
2014-09-26 |
Genmab As |
Production of heterodimeric proteins
|
|
CN104203982B
(zh)
|
2011-10-28 |
2018-08-31 |
特瓦制药澳大利亚私人有限公司 |
多肽构建体及其用途
|
|
WO2013093809A1
(en)
|
2011-12-23 |
2013-06-27 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
WO2013109994A1
(en)
|
2012-01-20 |
2013-07-25 |
Sea Lane Biotechnologies, Llc |
Surrobody cojugates
|
|
EP2818480B1
(en)
|
2012-02-24 |
2020-08-26 |
Alteogen Inc. |
Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
US9790268B2
(en)
|
2012-09-12 |
2017-10-17 |
Genzyme Corporation |
Fc containing polypeptides with altered glycosylation and reduced effector function
|
|
JP6392764B2
(ja)
|
2012-10-12 |
2018-09-19 |
エイディーシー・セラピューティクス・エス・アーＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａ |
ピロロベンゾジアゼピン−抗体結合体
|
|
LT2906251T
(lt)
|
2012-10-12 |
2017-12-11 |
Adc Therapeutics Sa |
Pirolobenzodiazepino-anti-cd22 antikūno konjugatai
|
|
WO2014057073A1
(en)
|
2012-10-12 |
2014-04-17 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
HRP20182129T1
(hr)
|
2012-10-12 |
2019-02-08 |
Adc Therapeutics Sa |
Konjugati protutijelo - pirolobenzodiazepin
|
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA2885305C
(en)
|
2012-10-12 |
2019-11-12 |
Spirogen Sarl |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
|
HUE045435T2
(hu)
|
2012-10-12 |
2019-12-30 |
Medimmune Ltd |
Pirrolobenzodiazepinek és konjugátumaik
|
|
JP6270859B2
(ja)
|
2012-10-12 |
2018-01-31 |
エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ |
ピロロベンゾジアゼピン−抗体結合体
|
|
EP2906250B1
(en)
|
2012-10-12 |
2018-05-30 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
US9353150B2
(en)
|
2012-12-04 |
2016-05-31 |
Massachusetts Institute Of Technology |
Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
|
|
EP2934602B1
(en)
|
2012-12-19 |
2019-02-27 |
Genentech, Inc. |
Methods and compositions for radiohalogen protein labeling
|
|
AU2013366493B2
(en)
|
2012-12-21 |
2017-08-24 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
CN103933575B
(zh)
|
2013-01-23 |
2017-09-29 |
上海新理念生物医药科技有限公司 |
一种三齿型连接子及其应用
|
|
KR102447350B1
(ko)
*
|
2013-02-08 |
2022-09-23 |
노파르티스 아게 |
면역접합체의 제조를 위한 항체의 변형에 사용되는 특정 부위
|
|
WO2014130879A2
(en)
|
2013-02-22 |
2014-08-28 |
Stem Centrx, Inc. |
Novel antibody conjugates and uses thereof
|
|
HK1219423A1
(zh)
|
2013-02-28 |
2017-04-07 |
Immunogen, Inc. |
包含细胞结合剂及细胞毒素剂的轭合物
|
|
US9999680B2
(en)
|
2013-02-28 |
2018-06-19 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents
|
|
TWI636063B
(zh)
*
|
2013-03-08 |
2018-09-21 |
美國禮來大藥廠 |
結合ｉｌ－２３之抗體
|
|
KR102420934B1
(ko)
|
2013-03-11 |
2022-07-15 |
젠자임 코포레이션 |
과글리코실화된 결합 폴리펩티드
|
|
CA2904044C
(en)
|
2013-03-13 |
2020-03-31 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP6444902B2
(ja)
|
2013-03-13 |
2018-12-26 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピン及びその結合体
|
|
CN105307685B
(zh)
|
2013-03-13 |
2019-03-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
KR102306490B1
(ko)
|
2013-03-15 |
2021-09-28 |
리제너론 파아마슈티컬스, 인크. |
생물학적 활성 분자, 그의 접합체 및 치료 용도
|
|
US11117975B2
(en)
|
2013-04-29 |
2021-09-14 |
Teva Pharmaceuticals Australia Pty Ltd |
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
|
|
ES2774976T3
(es)
|
2013-04-29 |
2020-07-23 |
Teva Pharmaceuticals Australia Pty Ltd |
Anticuerpos anti-CD38 y fusiones con interferón alfa-2b atenuado
|
|
US9803002B2
(en)
|
2013-05-31 |
2017-10-31 |
Genentench, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
MX369022B
(es)
|
2013-05-31 |
2019-10-25 |
Genentech Inc |
Anticuerpos anti-ácido teicoico de la pared celular y conjugados.
|
|
US9884126B2
(en)
|
2013-05-31 |
2018-02-06 |
Genentech, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
US10071170B2
(en)
|
2013-06-24 |
2018-09-11 |
Ablbio |
Antibody-drug conjugate having improved stability and use thereof
|
|
WO2015002486A1
(ko)
*
|
2013-07-03 |
2015-01-08 |
서울대학교산학협력단 |
시스테인으로 변형된 닭의 항체 및 이를 이용한 부위-특이적 접합
|
|
WO2015006043A1
(en)
*
|
2013-07-09 |
2015-01-15 |
Board Of Regents Of The University Of Nebraska |
Novel method of targeting glycoproteins to treat cancer
|
|
MX2016001862A
(es)
|
2013-08-12 |
2016-08-03 |
Genentech Inc |
Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo[e]indol, y metodos de uso y tratamiento.
|
|
SG11201601230RA
(en)
|
2013-08-26 |
2016-03-30 |
Regeneron Pharma |
Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
|
|
PE20160674A1
(es)
|
2013-08-28 |
2016-07-21 |
Stemcentrx Inc |
Metodos de conjugacion de anticuerpos especificos de sitio y composiciones
|
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015052532A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
|
RU2016122041A
(ru)
|
2013-11-06 |
2017-12-11 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Новые анти-клаудин антитела и способы их применения
|
|
JP6326137B2
(ja)
*
|
2013-11-19 |
2018-05-16 |
烟台▲榮▼昌生物工程有限公司Ｒｅｍｅｇｅｎ， Ｌｔｄ． |
抗ｈｅｒ２抗体及びその結合体
|
|
JP2017500028A
(ja)
|
2013-12-12 |
2017-01-05 |
アッヴィ・ステムセントルクス・エル・エル・シー |
新規の抗ｄｐｅｐ３抗体および使用方法
|
|
EP3082874A2
(en)
|
2013-12-16 |
2016-10-26 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
AU2014364927A1
(en)
|
2013-12-16 |
2016-07-07 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
|
JP6980384B2
(ja)
|
2013-12-16 |
2021-12-15 |
ジェネンテック， インコーポレイテッド |
１−（クロロメチル）−２，３−ジヒドロ−１ｈ−ベンゾ［ｅ］インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
|
EA201691683A1
(ru)
|
2014-02-21 |
2017-04-28 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Антитела против dll3 и конъюгаты антитело-лекарственное средство для применения при меланоме
|
|
CN104672330A
(zh)
*
|
2014-03-11 |
2015-06-03 |
南京任诺药业有限公司 |
用于构建放射性同位素偶联标记的ADC药物的改造抗体IgG1-CH-N267C
|
|
CN104788566A
(zh)
*
|
2014-03-11 |
2015-07-22 |
南京任诺药业有限公司 |
用于构建放射性同位素偶联标记的ADC药物的改造抗体IgG1-CH-V280C
|
|
EP4640239A2
(en)
|
2014-03-19 |
2025-10-29 |
Genzyme Corporation |
Site-specific glycoengineering of targeting moieties
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
PL3134125T3
(pl)
|
2014-04-25 |
2020-04-30 |
Pierre Fabre Médicament |
Koniugat przeciwciało-lek i jego zastosowanie do leczenia raka
|
|
UA120364C2
(uk)
|
2014-04-25 |
2019-11-25 |
Пьєр Фабр Медікамент |
Кон'югат антитіла до igf-1r з лікарським засобом
|
|
JP6835591B2
(ja)
|
2014-04-25 |
2021-02-24 |
ピエール、ファーブル、メディカマン |
Ｉｇｆ−１ｒ抗体および癌処置のためのアドレッシングビヒクルとしてのその使用
|
|
UA119352C2
(uk)
|
2014-05-01 |
2019-06-10 |
Тева Фармасьютикалз Острейліа Пті Лтд |
Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
|
|
WO2016008112A1
(en)
|
2014-07-16 |
2016-01-21 |
Medshine Discovery Inc. |
Linkers and application towards adc thereof
|
|
RU2021106673A
(ru)
|
2014-07-24 |
2021-11-25 |
Дженентек, Инк. |
Способы конъюгации агента с тиольным компонентом в белке, который содержит по меньшей мере одну трисульфидную связь
|
|
TW201617368A
(zh)
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗ｍｆｉ２抗體及使用方法
|
|
JP6531166B2
(ja)
|
2014-09-10 |
2019-06-12 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
|
JP6622293B2
(ja)
|
2014-09-12 |
2019-12-18 |
ジェネンテック， インコーポレイテッド |
アントラサイクリンジスルフィド中間体、抗体−薬物複合体、及び方法
|
|
AU2015314826A1
(en)
|
2014-09-12 |
2017-03-02 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP6730261B2
(ja)
|
2014-09-17 |
2020-07-29 |
ジェネンテック， インコーポレイテッド |
抗ｈｅｒ２抗体を含む免疫複合体
|
|
CA2959689A1
(en)
|
2014-09-17 |
2016-03-24 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
|
PL3204425T3
(pl)
|
2014-10-09 |
2021-03-08 |
Genzyme Corporation |
Glikomodyfikowane koniugaty przeciwciał z lekami
|
|
US10617670B2
(en)
*
|
2014-10-10 |
2020-04-14 |
Pfizer Inc. |
Synergistic auristatin combinations
|
|
EA037749B1
(ru)
|
2014-10-29 |
2021-05-18 |
Тева Фармасьютикалз Острэйлиа Пти Лтд |
ВАРИАНТЫ ИНТЕРФЕРОНА 2b
|
|
EP3223854A1
(en)
|
2014-11-25 |
2017-10-04 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
MX2017007231A
(es)
*
|
2014-12-03 |
2017-11-08 |
Genentech Inc |
Conjugados de rifamicina y anticuerpos contra el staphylococcuss aureus y usos de estos.
|
|
KR20170086121A
(ko)
|
2014-12-03 |
2017-07-25 |
제넨테크, 인크. |
4급 아민 화합물 및 그의 항체-약물 접합체
|
|
WO2016090038A1
(en)
|
2014-12-03 |
2016-06-09 |
Genentech, Inc. |
Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof
|
|
WO2016094517A1
(en)
*
|
2014-12-09 |
2016-06-16 |
Abbvie Inc. |
Bcl-xl inhibitory compounds and antibody drug conjugates including the same
|
|
SG11201704710PA
(en)
*
|
2014-12-09 |
2017-07-28 |
Abbvie Inc |
Bcl xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same
|
|
JP6862343B2
(ja)
*
|
2014-12-19 |
2021-04-21 |
アブリンクス エン．ヴェー． |
システイン結合ナノボディダイマー
|
|
KR20240091253A
(ko)
|
2015-02-16 |
2024-06-21 |
론자 리미티드 |
Cl 및/또는 ch1 돌연변이된 약물 접합용 항체
|
|
MX391249B
(es)
|
2015-03-17 |
2025-03-21 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos anti-muc16 y sus usos.
|
|
CN107995912A
(zh)
|
2015-03-27 |
2018-05-04 |
里珍纳龙药品有限公司 |
美登素类衍生物、其偶联物和使用方法
|
|
US10206942B2
(en)
|
2015-04-10 |
2019-02-19 |
Thomas Jefferson University |
Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytes
|
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
CN108064246A
(zh)
*
|
2015-06-15 |
2018-05-22 |
基因泰克公司 |
抗体和免疫结合物
|
|
NZ739830A
(en)
|
2015-07-12 |
2021-12-24 |
Hangzhou Dac Biotech Co Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
GB201514928D0
(en)
|
2015-08-21 |
2015-10-07 |
King S College London |
PDD compounds
|
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
|
US9669106B2
(en)
|
2015-10-26 |
2017-06-06 |
Pierre Fabre Medicament |
Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancer
|
|
RU2728568C2
(ru)
|
2015-10-26 |
2020-07-30 |
Пьер Фабр Медикамент |
Композиция для лечения рака, экспрессирующего igf-1r
|
|
WO2017112624A1
(en)
|
2015-12-21 |
2017-06-29 |
Bristol-Myers Squibb Company |
Variant antibodies for site-specific conjugation
|
|
WO2017117464A1
(en)
*
|
2015-12-30 |
2017-07-06 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
|
MX390630B
(es)
|
2016-01-25 |
2025-03-21 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados de los mismos y metodos de uso.
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
MX2018009800A
(es)
*
|
2016-02-12 |
2018-11-09 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
|
|
WO2017152083A1
(en)
|
2016-03-04 |
2017-09-08 |
Genentech, Inc. |
Process for the preparation of an antibody-rifamycin conjugate
|
|
EP3433621A1
(en)
|
2016-03-25 |
2019-01-30 |
H. Hoffnabb-La Roche Ag |
Multiplexed total antibody and antibody-conjugated drug quantification assay
|
|
JP2019515025A
(ja)
*
|
2016-04-04 |
2019-06-06 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
トポイソメラーゼ毒
|
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール．ピー．シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
WO2017197045A1
(en)
|
2016-05-11 |
2017-11-16 |
Movassaghi Mohammad |
Convergent and enantioselective total synthesis of communesin analogs
|
|
PL3458101T3
(pl)
|
2016-05-20 |
2021-05-31 |
F. Hoffmann-La Roche Ag |
Koniugaty PROTAC-przeciwciało i sposoby ich stosowania
|
|
WO2017205741A1
(en)
|
2016-05-27 |
2017-11-30 |
Genentech, Inc. |
Bioanalytical method for the characterization of site-specific antibody-drug conjugates
|
|
CN109476648B
(zh)
|
2016-06-06 |
2022-09-13 |
豪夫迈·罗氏有限公司 |
司维司群抗体-药物缀合物和使用方法
|
|
WO2018009811A1
(en)
|
2016-07-08 |
2018-01-11 |
Genentech, Inc. |
Use of human epididymis protein 4 (he4) for assessing responsiveness of muc 16-positive cancer treatment
|
|
EP3487522A4
(en)
|
2016-07-19 |
2020-04-01 |
Teva Pharmaceuticals Australia Pty Ltd |
Anti-cd47 combination therapy
|
|
WO2018027204A1
(en)
|
2016-08-05 |
2018-02-08 |
Genentech, Inc. |
Multivalent and multiepitopic anitibodies having agonistic activity and methods of use
|
|
KR102369014B1
(ko)
*
|
2016-08-16 |
2022-03-02 |
리제너론 파아마슈티컬스, 인크. |
혼합물로부터 개별 항체들을 정량하는 방법
|
|
RS64691B1
(sr)
*
|
2016-09-23 |
2023-11-30 |
Regeneron Pharma |
Bispecifična anti-muc16-cd3 antitela i konjugati anti-muc16 sa lekom
|
|
EP3522933B1
(en)
|
2016-10-05 |
2021-12-15 |
F. Hoffmann-La Roche AG |
Methods for preparing antibody drug conjugates
|
|
CN118846112A
(zh)
*
|
2016-10-08 |
2024-10-29 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物及其制备方法
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
KR102345175B1
(ko)
|
2016-11-14 |
2021-12-31 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
|
EP3548515A1
(en)
|
2016-12-01 |
2019-10-09 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
|
|
JP7244987B2
(ja)
*
|
2016-12-14 |
2023-03-23 |
シージェン インコーポレイテッド |
多剤抗体薬物コンジュゲート
|
|
AU2018218548A1
(en)
*
|
2017-02-08 |
2019-07-25 |
Pfizer Inc. |
Large scale production process for capped and un-capped antibody cysteines and their use in therapeutic protein conjugation
|
|
MX375568B
(es)
|
2017-02-08 |
2025-03-06 |
Medimmune Ltd |
Conjugados de pirrolobenzodiazepinas y anticuerpos
|
|
KR20200032243A
(ko)
|
2017-02-08 |
2020-03-25 |
에이디씨 테라퓨틱스 에스에이 |
피롤로벤조디아제핀-항체 컨주게이트
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
SI3612537T1
(sl)
|
2017-04-18 |
2022-10-28 |
Medimmune Limited |
Konjugati pirolobenzodiazepina
|
|
EP3612234B1
(en)
|
2017-04-20 |
2024-03-13 |
ADC Therapeutics SA |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
WO2018200585A1
(en)
|
2017-04-26 |
2018-11-01 |
Eureka Therapeutics, Inc. |
Cells expressing chimeric antigen receptors and secondary effectors and uses thereof
|
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
US11666657B2
(en)
*
|
2017-05-16 |
2023-06-06 |
Universite De Strasbourg |
Protein-drug conjugates and their use in the treatment of cancers
|
|
KR102442736B1
(ko)
|
2017-06-14 |
2022-09-16 |
에이디씨 테라퓨틱스 에스에이 |
항-cd19 adc의 투여를 위한 투약량 체제
|
|
CN108452321B
(zh)
*
|
2017-06-19 |
2021-11-26 |
四川百利药业有限责任公司 |
一种带酸性自稳定接头的抗体-药物偶联物
|
|
SG11202008821PA
(en)
*
|
2017-06-20 |
2020-10-29 |
Sichuan Baili Pharm Co Ltd |
Screening of fixed-point coupling sites of cysteine-modified antibody-toxin conjugate (tdc)
|
|
JP7504025B2
(ja)
*
|
2017-08-04 |
2024-06-21 |
アムジエン・インコーポレーテツド |
Ｃｙｓ－ｍａｂのコンジュゲーション方法
|
|
CN111065638B
(zh)
|
2017-08-18 |
2021-04-09 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂䓬缀合物
|
|
CN107583058B
(zh)
*
|
2017-09-20 |
2020-09-18 |
厉保秋 |
一种t-2毒素-抗体缀合物及其用途
|
|
US11364303B2
(en)
|
2017-09-29 |
2022-06-21 |
Pfizer Inc. |
Cysteine engineered antibody drug conjugates
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
WO2019084026A1
(en)
|
2017-10-24 |
2019-05-02 |
Genentech, Inc. |
(4-HYDROXYPYRROLIDIN-2-YL) -HETEROCYCLIC COMPOUNDS AND METHODS OF USE
|
|
WO2019084030A1
(en)
|
2017-10-24 |
2019-05-02 |
Genentech, Inc. |
(4-HYDROXYPYRROLIDIN-2-YL) -HYDROXAMATE COMPOUNDS AND METHODS OF USE
|
|
CA3081925A1
(en)
*
|
2017-11-18 |
2019-05-23 |
Nzola DE MAGALHAES |
Product and process for employing gc7 (n1-guanyl-1,7-diaminoheptane) based antigen binding conjugates in cancer therapy
|
|
CN110133271B
(zh)
*
|
2018-02-09 |
2022-12-13 |
北京豪迈生物工程股份有限公司 |
一种将抗体或其抗原结合片段共价结合至颗粒表面的方法
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
WO2019183523A1
(en)
|
2018-03-23 |
2019-09-26 |
Genentech, Inc. |
Hetero-bifunctional degrader compounds and their use as modulators of targeted ubiquination (vhl)
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN108727498B
(zh)
*
|
2018-04-24 |
2021-11-26 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CN108714220B
(zh)
*
|
2018-04-24 |
2021-11-19 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CN108727499B
(zh)
*
|
2018-04-24 |
2021-12-31 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CN108743966B
(zh)
*
|
2018-04-24 |
2021-10-19 |
四川百利药业有限责任公司 |
半胱氨酸改造的抗体-毒素偶联物
|
|
CA3101641A1
(en)
|
2018-06-04 |
2019-12-12 |
Intrexon Corporation |
Muc16 specific chimeric antigen receptors and uses thereof
|
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
|
WO2020055976A1
(en)
|
2018-09-11 |
2020-03-19 |
Genentech, Inc. |
Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain brd4 inhibitors for treating cancer
|
|
JP2022512716A
(ja)
|
2018-10-19 |
2022-02-07 |
メドイミューン・リミテッド |
ピロロベンゾジアゼピン複合体
|
|
CN112867510A
(zh)
|
2018-10-19 |
2021-05-28 |
免疫医疗有限公司 |
吡咯并苯并二氮杂䓬缀合物
|
|
WO2020123275A1
(en)
|
2018-12-10 |
2020-06-18 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
AU2019402097A1
(en)
|
2018-12-17 |
2021-06-10 |
Revitope Limited |
Twin immune cell engager
|
|
TWI874341B
(zh)
|
2018-12-18 |
2025-03-01 |
美商健生生物科技公司 |
產生異二聚體抗體之方法
|
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
|
US12109273B2
(en)
|
2019-02-15 |
2024-10-08 |
Wuxi Xdc Singapore Private Limited |
Process for preparing antibody-drug conjugates with improved homogeneity
|
|
TWI756633B
(zh)
|
2019-02-15 |
2022-03-01 |
大陸商上海藥明生物技術有限公司 |
具有改善的同質性的抗體－藥物綴合物、其藥物組合物、用途和製備方法
|
|
IL286326B2
(en)
|
2019-03-15 |
2025-10-01 |
Medimmune Ltd |
Azatidobenzodiazepine dimers and conjugates containing them for use in the treatment of cancer
|
|
CA3133757A1
(en)
|
2019-03-29 |
2020-10-08 |
Medimmune Limited |
Compounds and conjugates thereof
|
|
EP3947458A1
(en)
|
2019-04-03 |
2022-02-09 |
Genzyme Corporation |
Anti-alpha beta tcr binding polypeptides with reduced fragmentation
|
|
CN111825742B
(zh)
*
|
2019-04-18 |
2024-01-30 |
陈铭 |
Ctpa作为特种偶合剂用于氨基酸离子液体的多肽固相合成
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CA3142887A1
(en)
|
2019-06-13 |
2020-12-17 |
Bolt Biotherapeutics, Inc. |
Aminobenzazepine compounds, immunoconjugates, and uses thereof
|
|
CA3145050A1
(en)
|
2019-06-29 |
2021-01-07 |
Robert Zhao |
Conjugates of tubulysin derivatives and cell binding molecules and methods of making
|
|
EP4025254A1
(en)
|
2019-09-03 |
2022-07-13 |
Bolt Biotherapeutics, Inc. |
Aminoquinoline compounds, immunoconjugates, and uses thereof
|
|
KR20220077131A
(ko)
|
2019-09-30 |
2022-06-08 |
볼트 바이오테라퓨틱스 인코퍼레이티드 |
아마이드-연결된 아미노벤즈아제핀 면역접합체 및 이의 용도
|
|
WO2021072265A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
US20240123081A1
(en)
|
2019-10-25 |
2024-04-18 |
Medimmune, Llc |
Branched moiety for use in conjugates
|
|
US11654199B2
(en)
|
2019-10-25 |
2023-05-23 |
Bolt Biotherapeutics, Inc. |
Thienoazepine immunoconjugates, and uses thereof
|
|
CN110922476A
(zh)
*
|
2019-12-16 |
2020-03-27 |
蓝怡科技集团股份有限公司 |
一种生物素偶联抗体及其制备方法和应用
|
|
TW202140076A
(zh)
|
2020-01-22 |
2021-11-01 |
英商梅迪繆思有限公司 |
化合物及其軛合物
|
|
US20230097908A1
(en)
|
2020-01-22 |
2023-03-30 |
Medimmune Limited |
Compounds and conjugates thereof
|
|
JP2023524271A
(ja)
|
2020-05-08 |
2023-06-09 |
ボルト バイオセラピューティクス、インコーポレーテッド |
エラスターゼ－基質ペプチドリンカーイムノコンジュゲート、及びそれらの使用
|
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
|
GB202011993D0
(en)
|
2020-07-31 |
2020-09-16 |
Adc Therapeutics Sa |
ANTI-IL 13Ra2 antibodies
|
|
AU2021326516A1
(en)
|
2020-08-13 |
2023-04-13 |
Bolt Biotherapeutics, Inc. |
Pyrazoloazepine immunoconjugates, and uses thereof
|
|
EP4208259A2
(en)
|
2020-09-04 |
2023-07-12 |
NovaRock Biotherapeutics, Ltd. |
Nectin-4 antibodies and uses thereof
|
|
IL301041A
(en)
|
2020-09-11 |
2023-05-01 |
Medimmune Ltd |
Therapeutic B7-H4 binding molecules
|
|
WO2022125891A2
(en)
|
2020-12-11 |
2022-06-16 |
Bolt Biotherapeutics, Inc. |
Anti-cea immunoconjugates, and uses thereof
|
|
JP2023552792A
(ja)
|
2020-12-11 |
2023-12-19 |
ボルト バイオセラピューティクス、インコーポレーテッド |
抗ｈｅｒ２免疫複合体、及びその使用
|
|
US20220195066A1
(en)
|
2020-12-11 |
2022-06-23 |
Bolt Biotherapeutics, Inc. |
Anti-cea immunoconjugates, and uses thereof
|
|
KR20230118149A
(ko)
|
2020-12-11 |
2023-08-10 |
볼트 바이오테라퓨틱스 인코퍼레이티드 |
항-pd-l1 면역접합체, 및 그의 용도
|
|
EP4259211A1
(en)
|
2020-12-11 |
2023-10-18 |
Bolt Biotherapeutics, Inc. |
Anti-her2 immunoconjugates, and uses thereof
|
|
EP4046996A1
(en)
|
2021-02-19 |
2022-08-24 |
Universität Bielefeld |
Cryptophycin compounds and conjugates thereof
|
|
CN114957476A
(zh)
*
|
2021-02-23 |
2022-08-30 |
复旦大学 |
一种半胱氨酸工程化的结合人5t4的全人源纳米抗体
|
|
WO2022182415A1
(en)
|
2021-02-24 |
2022-09-01 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
WO2022197877A1
(en)
|
2021-03-19 |
2022-09-22 |
Genentech, Inc. |
Methods and compositions for time delayed bio-orthogonal release of cytotoxic agents
|
|
JP2024511088A
(ja)
|
2021-03-26 |
2024-03-12 |
ボルト バイオセラピューティクス、インコーポレーテッド |
２－アミノ－４－カルボキサミド－ベンゾアゼピン免疫複合体、及びその使用
|
|
CA3212907A1
(en)
|
2021-03-26 |
2022-09-29 |
Gary Brandt |
2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
|
|
GB202105187D0
(en)
|
2021-04-12 |
2021-05-26 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CA3216880A1
(en)
*
|
2021-04-16 |
2022-10-20 |
Novartis Ag |
Antibody drug conjugates and methods for making thereof
|
|
WO2023076599A1
(en)
|
2021-10-29 |
2023-05-04 |
Bolt Biotherapeutics, Inc. |
Tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof
|
|
CA3236930A1
(en)
|
2021-11-03 |
2022-04-21 |
Hangzhou Dac Biotech Co., Ltd. |
Specific conjugation of an antibody
|
|
CA3237211A1
(en)
|
2021-11-10 |
2023-05-19 |
Astrazeneca Ab |
Antibody molecules and conjugates
|
|
WO2023088966A1
(en)
|
2021-11-19 |
2023-05-25 |
Adc Therapeutics Sa |
Anti-psma conjugates
|
|
WO2023088963A1
(en)
|
2021-11-19 |
2023-05-25 |
Adc Therapeutics Sa |
Anti-il-13ralpha2 conjugates
|
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
|
EP4230222A1
(en)
|
2022-02-17 |
2023-08-23 |
Oxsonics Limited |
Combination therapy with an anti-axl antibody-pbd conjugate and nanocups
|
|
JP2025507736A
(ja)
|
2022-02-28 |
2025-03-21 |
アーデーセー セラピューティクス ソシエテ アノニム |
投薬レジメン
|
|
CR20240415A
(es)
|
2022-03-09 |
2024-11-07 |
Astrazeneca Ab |
MOLÉCULAS DE UNIÓN CONTRA FRa
|
|
AU2023229967A1
(en)
|
2022-03-11 |
2024-08-08 |
Astrazeneca Ab |
A SCORING METHOD FOR AN ANTI-FRα ANTIBODY-DRUG CONJUGATE THERAPY
|
|
KR20250029133A
(ko)
|
2022-06-27 |
2025-03-04 |
아스트라제네카 아베 |
암 치료를 위한 표피성장인자 수용체 티로신 키나제 억제제를 포함하는 조합물
|
|
EP4583919A1
(en)
|
2022-09-09 |
2025-07-16 |
MyricX Pharma Limited |
Antibody drug conjugate comprising nmt inhibitor and its use
|
|
CN120187759A
(zh)
|
2022-11-01 |
2025-06-20 |
海德堡医药研究有限责任公司 |
抗gucy2c抗体及其用途
|
|
EP4634227A1
(en)
*
|
2022-12-13 |
2025-10-22 |
Seagen Inc. |
Site-specific engineered cysteine antibody drug conjugates
|
|
AU2023393382A1
(en)
|
2022-12-14 |
2025-06-19 |
Pheon Therapeutics Ltd |
Cytotoxic compounds
|
|
WO2024137619A1
(en)
|
2022-12-20 |
2024-06-27 |
Bolt Biotherapeutics, Inc. |
Anti-claudin, bis-benzimid azole sting agonist immunoconjugates, and uses thereof
|
|
TW202432187A
(zh)
|
2022-12-23 |
2024-08-16 |
美商建南德克公司 |
小腦蛋白降解劑結合物及其用途
|
|
EP4410314A1
(en)
|
2023-02-02 |
2024-08-07 |
ADC Therapeutics SA |
Combination therapy comprising anti-cd22 antibody-drug conjugate and irak1 inhibitor
|
|
WO2024173387A1
(en)
|
2023-02-14 |
2024-08-22 |
Bolt Biotherapeutics, Inc. |
Aza-benzazepine immunoconjugates, and uses thereof
|
|
KR20250148670A
(ko)
|
2023-02-16 |
2025-10-14 |
아스트라제네카 아베 |
치료용 결합 분자를 사용한 암 치료를 위한 병용 요법
|
|
WO2024186626A1
(en)
|
2023-03-03 |
2024-09-12 |
Bolt Biotherapeutics, Inc. |
Aza-bicyclic sting agonist immunoconjugates, and uses thereof
|
|
KR20250152101A
(ko)
|
2023-03-13 |
2025-10-22 |
하이델베르크 파마 리서치 게엠베하 |
암 치료에의 사용을 위한 피하 투여 항체-약물 접합체
|
|
WO2024223899A1
(en)
|
2023-04-28 |
2024-10-31 |
Medimmune Limited |
B7-h4 therapeutic binding molecules for the treatment of cancer
|
|
WO2025083061A1
(en)
|
2023-10-17 |
2025-04-24 |
Adc Therapeutics Sa |
Anti-napi2b conjugates
|
|
WO2025083064A1
(en)
|
2023-10-17 |
2025-04-24 |
Adc Therapeutics Sa |
Anti-asct2 conjugates
|
|
WO2025083067A1
(en)
|
2023-10-17 |
2025-04-24 |
Adc Therapeutics Sa |
Anti-claudin-6 conjugates
|
|
EP4548936A1
(en)
*
|
2023-10-30 |
2025-05-07 |
BioNTech SE |
Antibody-drug conjugates having a tailor-made drug-to-antibody ratio
|
|
WO2025109097A2
(en)
|
2023-11-24 |
2025-05-30 |
Heidelberg Pharma Research Gmbh |
Novel nicotinamide phosphoribosyltransferase inhibitors and uses thereof
|
|
US20250186604A1
(en)
|
2023-12-06 |
2025-06-12 |
Adc Therapeutics Sa |
Anti-psma antibody conjugates
|
|
EP4566631A1
(en)
|
2023-12-06 |
2025-06-11 |
Heidelberg Pharma Research GmbH |
New antibody drug conjugate as well as methods of production and uses thereof
|
|
WO2025134068A1
(en)
|
2023-12-22 |
2025-06-26 |
Ac Immune Sa |
Antibody drug conjugates targeting proteinopathies, and uses thereof
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
EP4596569A1
(en)
*
|
2024-02-05 |
2025-08-06 |
Syndivia |
Site specific antibody drug conjugates and their process of preparation
|
|
GB202403391D0
(en)
|
2024-03-08 |
2024-04-24 |
Myricx Pharma Ltd |
Novel compounds and their use in therapy
|
|
GB202405758D0
(en)
|
2024-04-24 |
2024-06-05 |
King S College London |
Compounds
|
|
GB202407700D0
(en)
|
2024-05-30 |
2024-07-17 |
Francis Crick Institute Ltd |
F-actin binding agents
|